January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
iProgen Biotech Inc.
iProgen offers proprietary, modular platforms that enhances both the antibody delivery to tumor cells and antibody-receptor internalization. The platform unlocks numerous receptors that were previously overlooked or not considered for ADC development.